Author:
Fontana Robert J.,Lens Sabela,McPherson Stuart,Elkhashab Magdy,Ankoma-Sey Victor,Bondin Mark,dos Santos Ana Gabriela Pires,Xue Zhenyi,Trinh Roger,Porcalla Ariel,Zeuzem Stefan
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference31 articles.
1. World Health Organization. Global hepatitis report. Geneva: World Health Organization; 2017.
2. Huppe D, Serfert Y, Buggisch P, et al. Hepatitis C therapy in Germany: results from the german hepatitis C registry 4 years after approval of the new direct antiviral substances (DAAs). Wiesbaden: Viszeralmedizin; 2018.
3. Alazawi W, Cunningham M, Dearden J, Foster GR. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther. 2010;32(3):344–55.
4. Xu F, Moorman AC, Tong X, et al. All-Cause mortality and progression risks to hepatic decompensation and hepatocellular carcinoma in patients infected with hepatitis C virus. Clin Infect Dis. 2016;62(3):289–97.
5. Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Ann Intern Med. 2017;166(9):637–48.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献